Precigen, Inc. (PGEN)
NASDAQ: PGEN · Real-Time Price · USD
1.910
-0.060 (-3.05%)
At close: Feb 21, 2025, 4:00 PM
1.960
+0.050 (2.62%)
After-hours: Feb 21, 2025, 6:12 PM EST
Precigen Market Cap
Precigen has a market cap or net worth of $559.38 million as of February 21, 2025. Its market cap has increased by 57.13% in one year.
Market Cap
559.38M
Enterprise Value
536.50M
1-Year Change
57.13%
Ranking
Category
Stock Price
$1.91
Market Cap Chart
Since August 8, 2013, Precigen's market cap has decreased from $2.32B to $559.38M, a decrease of -75.89%. That is a compound annual growth rate of -11.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 559.40M | 70.55% |
| Dec 31, 2024 | 328.00M | -1.68% |
| Dec 29, 2023 | 333.60M | 5.44% |
| Dec 30, 2022 | 316.40M | -58.75% |
| Dec 31, 2021 | 767.00M | -59.45% |
| Dec 31, 2020 | 1.89B | 112.19% |
| Dec 31, 2019 | 891.50M | -0.66% |
| Dec 31, 2018 | 897.40M | -35.47% |
| Dec 29, 2017 | 1.39B | -51.74% |
| Dec 30, 2016 | 2.88B | -17.89% |
| Dec 31, 2015 | 3.51B | 26.82% |
| Dec 31, 2014 | 2.77B | 19.88% |
| Dec 31, 2013 | 2.31B | -0.51% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |